Northeast Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.2M | Buy |
54,340
+308
| +0.6% | +$315K | 2.4% | 12 |
|
|
2026
Q1 | $49.7M | Buy |
54,032
+6
| +0% | +$6.08K | 2.06% | 13 |
|
|
2025
Q4 | $58.1M | Sell |
54,026
-116
| -0.2% | -$111K | 2.27% | 12 |
|
|
2025
Q3 | $41.3M | Sell |
54,142
-473
| -0.9% | -$352K | 1.66% | 15 |
|
|
2025
Q2 | $42.6M | Sell |
54,615
-846
| -2% | -$657K | 1.82% | 15 |
|
|
2025
Q1 | $45.8M | Buy |
55,461
+1,983
| +4% | +$1.65M | 2.14% | 12 |
|
|
2024
Q4 | $41.3M | Buy |
53,478
+2,226
| +4% | +$1.84M | 1.83% | 16 |
|
|
2024
Q3 | $45.4M | Buy |
51,252
+778
| +2% | +$699K | 2.03% | 13 |
|
|
2024
Q2 | $45.7M | Buy |
50,474
+3,801
| +8% | +$3.04M | 2.15% | 11 |
|
|
2024
Q1 | $36.3M | Buy |
46,673
+5,361
| +13% | +$3.82M | 1.78% | 17 |
|
|
2023
Q4 | $24.1M | Buy |
41,312
+5,563
| +16% | +$3.25M | 1.29% | 27 |
|
|
2023
Q3 | $19.2M | Buy |
35,749
+6,048
| +20% | +$3.12M | 1.13% | 31 |
|
|
2023
Q2 | $13.9M | Buy |
29,701
+12,643
| +74% | +$5.3M | 0.79% | 41 |
|
|
2023
Q1 | $5.86M | Buy |
17,058
+975
| +6% | +$329K | 0.36% | 56 |
|
|
2022
Q4 | $5.88M | Buy |
16,083
+1,272
| +9% | +$451K | 0.37% | 56 |
|
|
2022
Q3 | $4.79M | Buy |
14,811
+1,388
| +10% | +$440K | 0.32% | 58 |
|
|
2022
Q2 | $4.35M | Buy |
13,423
+1,873
| +16% | +$562K | 0.28% | 62 |
|
|
2022
Q1 | $3.31M | Buy |
11,550
+1,774
| +18% | +$457K | 0.17% | 69 |
|
|
2021
Q4 | $2.7M | Sell |
9,776
-606
| -6% | -$154K | 0.13% | 77 |
|
|
2021
Q3 | $2.4M | Sell |
10,382
-30
| -0.3% | -$7.4K | 0.13% | 85 |
|
|
2021
Q2 | $2.39M | Sell |
10,412
-263
| -2% | -$52.8K | 0.13% | 87 |
|
|
2021
Q1 | $1.99M | Buy |
10,675
+75
| +0.7% | +$14.7K | 0.12% | 90 |
|
|
2020
Q4 | $1.79M | Sell |
10,600
-65
| -0.6% | -$9.71K | 0.11% | 91 |
|
|
2020
Q3 | $1.58M | Sell |
10,665
-17
| -0.2% | -$2.63K | 0.1% | 86 |
|
|
2020
Q2 | $1.75M | Buy |
10,682
+88
| +0.8% | +$13.5K | 0.13% | 78 |
|
|
2020
Q1 | $1.47M | Sell |
10,594
-395
| -4% | -$54.3K | 0.14% | 80 |
|
|
2019
Q4 | $1.44M | Hold |
10,989
| – | – | 0.11% | 92 |
|
|
2019
Q3 | $1.23M | Sell |
10,989
-194
| -2% | -$21.6K | 0.1% | 97 |
|
|
2019
Q2 | $1.24M | Sell |
11,183
-164
| -1% | -$19.3K | 0.1% | 94 |
|
|
2019
Q1 | $1.47M | Sell |
11,347
-112
| -1% | -$13.6K | 0.12% | 86 |
|
|
2018
Q4 | $1.33M | Sell |
11,459
-670
| -6% | -$74.8K | 0.13% | 88 |
|
|
2018
Q3 | $1.3M | Hold |
12,129
| – | – | 0.1% | 92 |
|
|
2018
Q2 | $1.03M | Sell |
12,129
-30
| -0.2% | -$2.46K | 0.09% | 99 |
|
|
2018
Q1 | $941K | Sell |
12,159
-690
| -5% | -$55.5K | 0.08% | 99 |
|
|
2017
Q4 | $1.08M | Buy |
12,849
+140
| +1% | +$11.9K | 0.09% | 96 |
|
|
2017
Q3 | $1.09M | Hold |
12,709
| – | – | 0.1% | 94 |
|
|
2017
Q2 | $1.05M | Hold |
12,709
| – | – | 0.1% | 94 |
|
|
2017
Q1 | $1.07M | Hold |
12,709
| – | – | 0.1% | 95 |
|
|
2016
Q4 | $935K | Sell |
12,709
-459
| -3% | -$34.2K | 0.09% | 99 |
|
|
2016
Q3 | $1.06M | Sell |
13,168
-173
| -1% | -$13.8K | 0.11% | 96 |
|
|
2016
Q2 | $1.05M | Hold |
13,341
| – | – | 0.11% | 93 |
|
|
2016
Q1 | $961K | Sell |
13,341
-496
| -4% | -$37.5K | 0.1% | 98 |
|
|
2015
Q4 | $1.17M | Hold |
13,837
| – | – | 0.12% | 88 |
|
|
2015
Q3 | $1.16M | Buy |
13,837
+143
| +1% | +$12.1K | 0.13% | 90 |
|
|
2015
Q2 | $1.14M | Sell |
13,694
-101
| -0.7% | -$7.7K | 0.12% | 95 |
|
|
2015
Q1 | $1M | Buy |
13,795
+35
| +0.3% | +$2.49K | 0.1% | 101 |
|
|
2014
Q4 | $949K | Sell |
13,760
-103
| -0.7% | -$6.95K | 0.09% | 107 |
|
|
2014
Q3 | $899K | Buy |
13,863
+1,533
| +12% | +$97.1K | 0.09% | 108 |
|
|
2014
Q2 | $767K | Buy |
12,330
+2,475
| +25% | +$148K | 0.08% | 112 |
|
|
2014
Q1 | $580K | Buy |
9,855
+142
| +1% | +$7.92K | 0.06% | 118 |
|
|
2013
Q4 | $495K | Sell |
9,713
-85
| -0.9% | -$4.26K | 0.06% | 118 |
|
|
2013
Q3 | $493K | Sell |
9,798
-325
| -3% | -$17K | 0.06% | 116 |
|
|
2013
Q2 | $497K | Buy |
+10,123
| New | +$551K | 0.06% | 111 |
|
Other funds holding LLY
SC
ONB
GIM
Northeast Investment Management's LLY Position: Q2 2026 in Review
Northeast Investment Management increased its Eli Lilly (LLY) stake by 0.57% in Q2 2026, buying an estimated $315K and bringing the position to 54,340 shares worth $65.2M. The position accounts for 2.4% of the portfolio, ranked #12.
Northeast Investment Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Northeast Investment Management held 54,340 shares of Eli Lilly worth $65.2M as of Q2 2026.
- Northeast Investment Management bought 308 Eli Lilly shares in Q2 2026, an estimated $315K.
- Eli Lilly made up 2.4% of Northeast Investment Management's portfolio in Q2 2026, its #12 holding.
- Northeast Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.